Zytex Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -6.67%
(FY 2023)
- Profit -110.59%
(FY 2023)
- Ebitda 338.56%
(FY 2023)
- Net Worth -0.66%
(FY 2023)
- Total Assets 0.52%
(FY 2023)
About Zytex Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rashesh Doshi, Jayraj Doshi, Dhansukh Doshi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2006PTC160565
- Company No.
160565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Zytex Biotech Private Limited offer?
Zytex Biotech Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Protein Powder, Flavours & Aromatics, Food Stabilizer, Digestive System Drugs & Medicines, Digestive Drugs, Natural Sweetener, Artificial Sweetener, Food Additive, Milk & Dairy Products.
Who are the key members and board of directors at Zytex Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashesh Doshi  | Director | 17-Mar-2006 | Current |
| Jayraj Doshi | Director | 17-Mar-2006 | Current |
| Dhansukh Doshi | Director | 17-Mar-2006 | Current |
| Ashwin Doshi | Director | 17-Mar-2006 | Current |
Financial Performance and Corporate Structure Insights of Zytex Biotech.
Zytex Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.67% decrease. The company also saw a substantial fall in profitability, with a 110.59% decrease in profit. The company's net worth dipped by a decrease of 0.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zytex Biotech?
In 2023, Zytex Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Idori India Private LimitedActive 13 years 8 monthsRashesh Doshi and Jayraj Doshi are mutual person
Zytex (India) Private LimitedActive 26 years 25 daysRashesh Doshi, Jayraj Doshi and 2 more are mutual person
- Zytex International Private Limited ZytexActive 18 years 8 months
Rashesh Doshi, Jayraj Doshi and 2 more are mutual person
General Textilies Stores Pvt LtdActive 82 years 8 monthsRashesh Doshi, Jayraj Doshi and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zytex Biotech?
Zytex Biotech has a workforce of 155 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zytex Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zytex Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
